Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC
- Conditions
- Interventions
- First Posted Date
- 2018-12-07
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 40
- Registration Number
- NCT03769103
- Locations
- 🇨🇦
BC Cancer, Vancouver Centre, Vancouver, British Columbia, Canada
🇨🇦Princess Margaret Hospital, Toronto, Ontario, Canada
🇨🇦Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases
- Conditions
- Interventions
- First Posted Date
- 2018-10-03
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 250
- Registration Number
- NCT03694015
- Locations
- 🇨🇦
London Health Sciences Centre, London, Ontario, Canada
🇨🇦Princess Margaret Cancer Centre, Toronto, Ontario, Canada
🇨🇦BC Cancer, Vancouver, British Columbia, Canada
MSG Use With 18F-DCFPyL PET/CT Imaging
- Conditions
- Interventions
- First Posted Date
- 2018-10-03
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 10
- Registration Number
- NCT03693742
- Locations
- 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada
US-CT Fusion for Post Implant Dosimetry
- Conditions
- First Posted Date
- 2018-10-02
- Last Posted Date
- 2020-01-27
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 25
- Registration Number
- NCT03692104
- Locations
- 🇨🇦
BC Cancer, Kelowna, British Columbia, Canada
DOTATOC PET/CT for Imaging NET Patients
- First Posted Date
- 2018-07-11
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 800
- Registration Number
- NCT03583528
- Locations
- 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada
Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant Chemotherapy
- Conditions
- Interventions
- First Posted Date
- 2018-06-25
- Last Posted Date
- 2018-06-25
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 46
- Registration Number
- NCT03566394
A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX
- Conditions
- Interventions
- First Posted Date
- 2018-03-01
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 6
- Registration Number
- NCT03450018
- Locations
- 🇨🇦
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
🇨🇦BC Cancer - Vancouver, Vancouver, British Columbia, Canada
LDR vs. HDR Brachytherapy for Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2018-02-08
- Last Posted Date
- 2023-12-15
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 140
- Registration Number
- NCT03426748
- Locations
- 🇨🇦
British Columbia Cancer Agency Center for the Southern Interior, Kelowna, British Columbia, Canada
OCT-AF Imaging of Pre-cancers of Vulva and Cervix
- Conditions
- Interventions
- First Posted Date
- 2017-09-18
- Last Posted Date
- 2024-03-18
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 20
- Registration Number
- NCT03285841
- Locations
- 🇨🇦
Vancouver General Hospital Women's Clinic, Vancouver, British Columbia, Canada
PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers.
- Conditions
- Interventions
- First Posted Date
- 2017-09-15
- Last Posted Date
- 2018-07-11
- Lead Sponsor
- British Columbia Cancer Agency
- Target Recruit Count
- 22
- Registration Number
- NCT03283943
- Locations
- 🇨🇦
BC Cancer Agency, Vancouver, British Columbia, Canada